Intravenous amiodarone or magnesium sulphate is not cost‐beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery
- Treggiari‐Venzi, M. M. et al
- swissbib.ch:(NATIONALLICENCE)oxford-10.1093/bja/85.5.690
Main file(s):
|
|
|||||||
| version 1 |
| ||||||